Nipro Diagnostics promotes senior execs
FT. LAUDERDALE, Fla. — Nipro Diagnostics, a provider of diabetes monitoring and management products, announced the promotion of Gregg Johnson to SVP consumer healthcare and Lisa Nardi to VP marketing. Both will continue reporting to Scott Verner, Nipro president.
Johnson, a 10-year company veteran, joined Nipro in October 1999 as VP new business development. He was a key architect of the company’s unique co-branding strategy, which contributed to Nipro’s growth over the past 10 years, according to the company. In his new role, Johnson will assume management responsibility for all retail, distribution, mail service, managed markets and government channels in North America.
“Gregg has been synonymous with success at Nipro Diagnostics,” Verner said. “[He] has been a critical factor in our company’s growth, helping to guide us through every major company milestone — start-up, IPO and our successful acquisition by Nipro Corp. Elevating Gregg’s leadership role into every channel we serve will help us continue to provide the highest level of support to customers, and to grow our business.”
Nardi joined Nipro in 2004, and has been responsible for leading the development of the company’s strategic marketing programs. In her new role, Nardi will manage marketing efforts in support of managed markets and professional marketing, in addition to her product and channel marketing responsibilties.
“Lisa has brought the highest level of strategic discipline to our product development and supporting marketing efforts,” Verner said. “[She] has positioned us as a market leader by successfully launching new product technologies like our TRUEresult and TRUE2go blood-glucose monitoring systems, and by developing comprehensive marketing programs that raise awareness and drive easy, affordable access to our product portfolio, especially in support to our business partners.”
Nature’s Health Connection’s Australian Dream achieves record sales
REDFORD, Mich. — Nature’s Health Connection said its over-the-counter pain-relief cream has garnered record retail sales.
Sales for Australian Dream — a Food and Drug Administration-approved odorless, greaseless, dye-free and capsaicin-free cream — increased more than 145%, according to the company. Nature’s Health Connection attributed the sales spike to a 30-second television commercial.
Australian Dream is designed to treat minor aches and pains associated with osteo- and rheumatoid arthritis, as well as other muscle ailments.
Australian Dream is available at select Walgreens locations and online at AustralianDream.com.
Hi-Tech Pharmacal acquires candidiasis treatment
AMITYVILLE, N.Y. — Generic drug maker Hi-Tech Pharmacal has acquired the rights to a drug for mouth infections, the company said Monday.
Hi-Tech said it acquired nystatin oral suspension from Bausch & Lomb for an undisclosed sum. The drug is used to treat candidiasis, a fungal infection, in the mouth.
The market for the drug is $23 million, according to IMS Health.